Episodes

  • Optimizing the Right Team for the Right Moment

    Optimizing the Right Team for the Right Moment
    Jun 12 2024
    Episode two of "The Power of Persistence" delves into the vital role that people play in the success of biotech companies. Host Jennifer LW Fink is joined by Holly May, President of BioLineRx US, who shares insights on building and optimizing the right team for a biotech startup. Holly emphasizes the importance of hiring the right people, nurturing their development, and fostering a culture of growth and innovation. The episode explores the challenges of scaling up a company's team while maintaining a focus on purpose and culture.
    Show More Show Less
    22 mins
  • From Incubation to Laser-Focused Biotech Innovation

    From Incubation to Laser-Focused Biotech Innovation
    Jun 5 2024
    In the inaugural episode, we explore the origins of BioLineRx and its transformation from a biotech incubator to a fully-fledged biotech company. Joined by Phil Serlin, CEO of BioLineRx, we uncover the company's early days, its broad pipeline spanning various therapeutic areas, and the strategic decision-making process that led to its evolution. From strategic evaluations to pivoting towards oncology and hematology, this episode highlights the importance of persistence and strategic adaptability in the biotech industry.
    Show More Show Less
    20 mins
  • Looking Ahead: Pipeline Development

    Looking Ahead: Pipeline Development
    Jun 5 2024
    Episode three of "The Power of Persistence" focuses on pipeline development in the biotech industry. Phil Serlin, CEO of BioLineRX, discusses how companies balance launching one product while maintaining pipeline development. Phil emphasizes the versatility of their platform molecule and the various applications it offers, such as stem cell mobilization for different transplantation types and gene therapy. Phil shares insights into how BioLineRX identifies potential partners and leverages existing expertise to expand their pipeline strategically. The discussion underscores the dynamic nature of the biotech industry and the need for companies to seize the moment while preparing for the future.
    Show More Show Less
    16 mins